Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
104,849,534
-
Total 13F shares
-
83,236,471
-
Share change
-
+1,165,444
-
Total reported value
-
$10,771,794,424
-
Put/Call ratio
-
27%
-
Price per share
-
$129.46
-
Number of holders
-
408
-
Value change
-
+$210,287,311
-
Number of buys
-
211
-
Number of sells
-
172
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2024
As of 31 Mar 2024,
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) was held by
408 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,236,471 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, Capital International Investors, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, FARALLON CAPITAL MANAGEMENT LLC, STATE STREET CORP, Bank of New York Mellon Corp, and T. Rowe Price Investment Management, Inc..
This page lists
408
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.